Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Taiwan University Hospital |
---|---|
Information provided by: | National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT00173953 |
The aims of this study are 1) to determine the cytokines produced by both Th1 and Th2 subsets in gastric antral biopsy specimens from Taiwanese patients before and after anti H. pylori therapy; 2) to obtain a detailed phenotypic characterization and distribution pattern of mucosal lymphocytes in H. pylori-associated gastritis and to define possible contributing immune mechanisms responsible for the chronicity of the disease and its associated lesions.
Condition | Intervention |
---|---|
Duodenal Ulcer Gastric Ulcer Dyspepsia |
Procedure: immune response |
Study Type: | Interventional |
Study Design: | Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Lymphocytic Subsets and Cytokine Production in the Gastric Samples of Patients With Helicobacter Pylori Infection |
Estimated Enrollment: | 50 |
Study Start Date: | January 2001 |
Estimated Study Completion Date: | October 2001 |
Helicobacter pylori, a Gram-negative spiral bacterium, has been first isolated from a patient with chronic active gastritis since 1982. Recent studies strongly suggest that chronic infection with H. pylori is tightly associated with chronic gastritis, peptic ulcer, and gastric carcinoma. However, only a minority of infected people develop signs and symptoms of gastric pathology. Thus, both host and microbial factors may lead to different outcomes of infection. In spite of high prevalence in general population and increasing clinical attention has been paid on this infection, the knowledge of pathogenic mechanism of H. pylori infection is still limited and little is known about the role of host immune response in the pathogenesis of disease.The aims of this study are 1) to determine the cytokines produced by both Th1 and Th2 subsets in gastric antral biopsy specimens from Taiwanese patients before and after anti H. pylori therapy; 2) to obtain a detailed phenotypic characterization and distribution pattern of mucosal lymphocytes in H. pylori-associated gastritis and to define possible contributing immune mechanisms responsible for the chronicity of the disease and its associated lesions.
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Taiwan | |
Department of Internal Medicine, National Taiwan University Hospital | |
Taipei, Taiwan, 100 |
Principal Investigator: | Jyh-Chin Yang, M.D. | Department of Internal Medicine, National Taiwan University Hospital |
Study ID Numbers: | 90M010, 90M010 |
Study First Received: | September 12, 2005 |
Last Updated: | September 13, 2005 |
ClinicalTrials.gov Identifier: | NCT00173953 |
Health Authority: | Taiwan: Department of Health |
H. pylori、immune response、lymphocytic subsets、cytokine |
Stomach Ulcer Signs and Symptoms Stomach Diseases Digestive System Diseases Signs and Symptoms, Digestive Gastrointestinal Diseases |
Ulcer Intestinal Diseases Dyspepsia Duodenal Diseases Peptic Ulcer Duodenal Ulcer |
Pathologic Processes |